Senior insider sale
Chief Financial Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$14.14M
160K shares
What this filing means
MOKARI ATABAK plans to sell 160K shares of CORCEPT THERAPEUTICS INC valued at approximately $14.14M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/30/2026ACC: 0001972481-26-000239
Officer· Chief Financial Officer
Since Mar 2021
160K
Shares to sell
$14.14M
Approx. market value
40K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercises
Equity Compensation
2/13/2023
40KTotal acquired40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/13/2023 | Stock Option Exercises Equity Compensation | 40K | — |
| Total | 40K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
40K
Market value
$3.51M
7/15/2026
—Completed
Units to sell
40K
Market value
$3.25M
6/15/2026
—Completed
Units to sell
40K
Market value
$2.80M
6/1/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
40K
Market value
$4.59M
7/30/2026
Total
Units
160K
Value
$14.14M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/15/2026 | 40K | $3.51M | — | Completed |
6/15/2026 | 40K | $3.25M | — | Completed |
6/1/2026 | 40K | $2.80M | — | Completed |
| Planned — Approximate Date | ||||
7/30/2026 | 40K | $4.59M | Nasdaq | Planned |
| Total | 160K | $14.14M | ||